NAFLD-derived exosomes inhibited YAP phosphorylation, decreased the levels of IL-6 and TNF-α, and reduced the ratio of LC3II/LC3I protein in pancreatic cells. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.